Establishment Labs director files Form 4 showing large sale and small purchase
Rhea-AI Filing Summary
Lewin Nicholas Sheridan, identified as a director of Establishment Labs Holdings, filed a Form 4 dated 08/14/2025 reporting insider transactions in the company’s common stock. The filing shows a purchase of 2,600 common shares at $37.85 and separately lists a disposition of 1,075,923 common shares. Following the reported transactions, the Form 4 shows 19,090 shares beneficially owned, held indirectly. A footnote states the shares are held by the reporting person’s spouse. The Form was signed by the company’s CFO by power of attorney on 08/14/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Form 4 reports a large disposition of 1,075,923 shares and a small purchase of 2,600 shares at $37.85; beneficial ownership is 19,090 shares.
The disclosure is factual and quantifies the insider activity: a purchase of 2,600 shares at $37.85 and a reported sale/Disposition of 1,075,923 shares. Beneficial ownership after the reported transactions is shown as 19,090 shares held indirectly, with a footnote that those shares are held by the reporting person’s spouse. The filing was executed by the CFO by power of attorney. As presented, this Form 4 is a routine Section 16 disclosure that documents significant movement in holdings but provides no explanation for the disposition.
TL;DR: Large reported disposition alongside a small purchase and spouse-held shares warrant attention, though the Form 4 itself is a standard disclosure.
The Form 4 clearly records both an acquisition (2,600 shares at $37.85) and a substantial disposition (1,075,923 shares). It also notes indirect ownership of 19,090 shares via the reporting person’s spouse. The document is signed by the CFO under power of attorney, which is an accepted administrative practice. The filing is material in size but contains no narrative explaining the transfer or timing beyond the dates shown.